AU5359094A - Oral tolerance and immune suppression in the treatment of aids - Google Patents

Oral tolerance and immune suppression in the treatment of aids

Info

Publication number
AU5359094A
AU5359094A AU53590/94A AU5359094A AU5359094A AU 5359094 A AU5359094 A AU 5359094A AU 53590/94 A AU53590/94 A AU 53590/94A AU 5359094 A AU5359094 A AU 5359094A AU 5359094 A AU5359094 A AU 5359094A
Authority
AU
Australia
Prior art keywords
aids
treatment
immune suppression
oral tolerance
tolerance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53590/94A
Inventor
Larry I Benowitz
Carleen A Irwin
J. Roberto Trujillo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Cincinnati Childrens Hospital Medical Center
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cincinnati Childrens Hospital Medical Center, Childrens Medical Center Corp filed Critical Cincinnati Childrens Hospital Medical Center
Publication of AU5359094A publication Critical patent/AU5359094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU53590/94A 1992-10-13 1993-10-13 Oral tolerance and immune suppression in the treatment of aids Abandoned AU5359094A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95977192A 1992-10-13 1992-10-13
US959771 1992-10-13
PCT/US1993/009797 WO1994008618A1 (en) 1992-10-13 1993-10-13 Oral tolerance and immune suppression in the treatment of aids

Publications (1)

Publication Number Publication Date
AU5359094A true AU5359094A (en) 1994-05-09

Family

ID=25502387

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53590/94A Abandoned AU5359094A (en) 1992-10-13 1993-10-13 Oral tolerance and immune suppression in the treatment of aids

Country Status (2)

Country Link
AU (1) AU5359094A (en)
WO (1) WO1994008618A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals

Also Published As

Publication number Publication date
WO1994008618A1 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
AU3519893A (en) Antitumor compositions and methods of treatment
AU5793396A (en) Human interferon tau compositions and methods of use
AU673703B2 (en) Injector and use of the same
AU4205789A (en) Method and composition for the treatment and prevention of viral infections
AU2199092A (en) Prosthesis press and method of using the same
IL107617A0 (en) Very small magnetite-dextran particles and their preparation
AU5343394A (en) Orthosis and prosthesis
EP0497204A3 (en) Medical member and method of manufacturing the same
IL112041A0 (en) Methods of inhibiting atrophy of the skin and vagina
AU4098393A (en) Laminate and use of the same
GB9301802D0 (en) Manufacture and processing of components
AU8044491A (en) Antitumor compositions and methods of treatment
AU5590696A (en) Use of quinones in the treatment of cancer or AIDS
AU8427091A (en) Gamma-carboxylase and methods of use
AU4812393A (en) Use of rapamycin in the treatment of aids
HUP9800829A3 (en) Collagen-based methods and formulations for the treatment of immune system-mediated diseases
AU4118393A (en) Human crabp-I and crabp-II
AU4319393A (en) Use of indolocarbazols in aids treatment
AU5359094A (en) Oral tolerance and immune suppression in the treatment of aids
AU4581193A (en) Improvements in and relating to dentistry
AU3530495A (en) Treatment of periodontal and acute gingival infections
AU3456793A (en) Macrocyclic compounds in the prophylactic treatment of aids
EP0512354A3 (en) Hearing aid in the form of an ear-ring
GB9111885D0 (en) Nerve growth factor for use in the prevention and treatment of viral infections
AU1485197A (en) Diamines in the treatment of arrhythmia